PA
CLGN icon

Parallel Advisors’s CollPlant Biotechnologies CLGN Stock Holding History

Parallel Advisors’s Portfolio CLGN Stock Details CLGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
71
– – ﹤0.01% 3906
2026
Q1 		$38 Sell
71
-3,182
-98% -$3.21K ﹤0.01% 3800
2025
Q4 		$4.55K Hold
3,253
– – ﹤0.01% 2879
2025
Q3 		$8.75K Sell
3,253
-1
-0% -$2 ﹤0.01% 2576
2025
Q2 		$4.42K Hold
3,254
– – ﹤0.01% 2786
2025
Q1 		$8.39K Buy
3,254
+1
+0% +$4 ﹤0.01% 2502
2024
Q4 		$11.7K Hold
3,253
– – ﹤0.01% 2361
2024
Q3 		$16.2K Sell
3,253
-1
-0% -$5 ﹤0.01% 2201
2024
Q2 		$16.2K Sell
3,254
-824
-20% -$4.57K ﹤0.01% 2098
2024
Q1 		$21.8K Buy
4,078
+4,007
+5,644% +$21.7K ﹤0.01% 1931
2023
Q4 		$454 Sell
71
-8,485
-99% -$46.4K ﹤0.01% 3071
2023
Q3 		$47.7K Sell
8,556
-1,058
-11% -$7K ﹤0.01% 1418
2023
Q2 		$78.5K Hold
9,614
– – ﹤0.01% 1187
2023
Q1 		$67.5K Sell
9,614
-3,025
-24% -$29.7K ﹤0.01% 1226
2022
Q4 		$106K Sell
12,639
-3,743
-23% -$25.6K ﹤0.01% 970
2022
Q3 		$111K Hold
16,382
– – 0.01% 921
2022
Q2 		$131K Hold
16,382
– – 0.01% 857
2022
Q1 		$192K Sell
16,382
-3,684
-18% -$40.5K 0.01% 750
2021
Q4 		$328K Sell
20,066
-1,228
-6% -$21.9K 0.01% 577
2021
Q3 		$360K Buy
21,294
+16,995
+395% +$305K 0.01% 505
2021
Q2 		$91K Sell
4,299
-823
-16% -$13.2K ﹤0.01% 981
2021
Q1 		$69K Buy
5,122
+1,934
+61% +$29.2K ﹤0.01% 1035
2020
Q4 		$34K Buy
+3,188
New +$25.8K ﹤0.01% 1254

Other funds holding CLGN

PA
Pinnacle Associates New York $9.16B AUM 63.5% 1-Year Est. Return
WPC
Waters Parkerson & Co New Orleans, Louisiana $2.03B AUM 17.65% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return
SFG
Strive Financial Group Carmel, Indiana $231M AUM

Parallel Advisors's CLGN Position: Q2 2026 in Review

Parallel Advisors held its CollPlant Biotechnologies (CLGN) position steady in Q2 2026 at 71 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3906.

Parallel Advisors first reported a position in CLGN in Q4 2020 and has held it in 23 quarters since. The position peaked at $360K in Q3 2021. 6 funds tracked by Wall St. Rank hold CLGN as of Q2 2026.

  • Parallel Advisors held 71 shares of CollPlant Biotechnologies worth $25 as of Q2 2026.
  • Parallel Advisors left its CollPlant Biotechnologies share count unchanged in Q2 2026.
  • CollPlant Biotechnologies made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3906 holding.
  • Parallel Advisors first reported a position in CollPlant Biotechnologies in Q4 2020 and has held it in 23 quarters since.
  • Parallel Advisors's CollPlant Biotechnologies position peaked at $360K in Q3 2021.
  • 6 funds tracked by Wall St. Rank held CollPlant Biotechnologies as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.